欧洲慢性疼痛脊髓刺激装置市场预测至 2030 年 - 区域分析 - 按产品类型（可充电和不可充电）、应用（腰椎间盘功能衰竭综合症、复杂性局部疼痛综合症、退行性椎间盘疾病等）和最终用户（医院、门诊手术中心等）

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030

No. of Pages: 157    |    Report Code: BMIRE00030432    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Spinal Cord Stimulation Device for Chronic Pain Market
Free Sample Buy Now
2022 年，用于慢性疼痛的脊髓刺激装置市场价值为 7.9987 亿美元，预计到 2030 年将达到 14.1201 亿美元；预计 2022 年至 2030 年的复合年增长率为 7.4%。

为脊髓损伤提供有效治疗的康复和专科中心推动了用于慢性疼痛的脊髓刺激装置市场的发展

根据美国国立卫生研究院的一份报告，专门的 SCI 护理中心最早在英国建立，目的是改善患者的护理和神经康复。SCI 三级护理中心旨在改善急性 SCI 患者的临床结果和神经康复。此外，德国海德堡大学医院的脊髓损伤中心是唯一一家致力于 SCI 治疗和研究的学术中心。海德堡大学医院的工作人员约有 145 名，每年为约 1,500 名患有急性或慢性脊髓损伤的患者提供治疗，其中 1,000 名接受门诊治疗。

脊髓刺激装置在康复中心得到广泛采用。基于这些设备的治疗方法在身体和心理上支持患者，以在短时间内最大限度地恢复他们的神经系统和整体健康。位于柏林的 Walk Again Center 就是一个治疗神经系统疾病的康复中心的例子。该康复中心采用药物和技术来治疗 SCI。它使用创新的医疗程序，包括结构和神经可塑性，医生为患有脑损伤的患者提供治疗。因此，先进的康复中心和专门的中心为欧洲慢性疼痛脊髓刺激设备市场提供了增长机会。

欧洲慢性疼痛脊髓刺激装置市场概览

欧洲慢性疼痛脊髓刺激装置市场按地区划分，包括德国、法国、意大利、西班牙、英国、瑞士、荷兰、瑞典和欧洲其他地区。不断增长的医疗索赔和相关成本、不断增加的行政交易以及供应链跟踪中的慢性疼痛脊髓刺激装置平台是推动市场增长的主要因素。例如，在意大利，医院的脊髓治疗完全由意大利国家医疗服务体系 (NHS) 承保。因此，意大利民众对 SCI 的有效治疗方法有很高的认识。因此，适当的 SCI 健康保险条款的可用性意味着意大利的医院和专科中心对脊髓刺激装置的需求很高。

欧洲慢性疼痛脊髓刺激装置市场收入及预测至 2030 年（百万美元）

欧洲慢性疼痛脊髓刺激装置市场细分

慢性疼痛脊髓刺激装置市场根据产品类型、应用、最终用户和国家/地区进行细分。

根据产品类型，慢性疼痛脊髓刺激装置市场分为可充电和不可充电。可充电部分在 2022 年占有较大份额。

在应用方面，慢性疼痛脊髓刺激装置市场细分为腰椎间盘衰竭综合征、复杂区域疼痛综合征、退行性椎间盘疾病等。复杂区域疼痛综合征部分在 2022 年占有最大份额。

按最终用户划分，慢性疼痛脊髓刺激装置市场细分为医院、门诊手术中心 (ASCS) 和其他。 2022 年，医院部门占据了最大的份额。

根据国家/地区，慢性疼痛脊髓刺激装置市场分为德国、法国、英国、西班牙、意大利、瑞士、瑞典、波兰、比利时、斯洛伐克、捷克共和国、希腊、爱尔兰、荷兰和欧洲其他地区。2022 年，德国在慢性疼痛脊髓刺激装置市场占据主导地位。

波士顿科学公司、雅培实验室、美敦力公司、Biotronik SE & Co KG、Nevro Corp、Cirtec Medical Corp 和 Synapse Biomedical Inc 是欧洲慢性疼痛脊髓刺激装置市场的一些领先公司。

Europe Spinal Cord Stimulation Device for Chronic Pain Strategic Insights

Strategic insights for Europe Spinal Cord Stimulation Device for Chronic Pain involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/europe-spinal-cord-stimulation-device-for-chronic-pain-market-strategic-framework.webp
Get more information on this report

Europe Spinal Cord Stimulation Device for Chronic Pain Report Scope

Report Attribute Details
Market size in 2022 US$ 799.87 Million
Market Size by 2030 US$ 1,412.01 Million
Global CAGR (2022 - 2030) 7.4%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 产品类型
  • 可充电和不可充电
By 应用
  • 腰椎间盘突出症
  • 复杂性局部疼痛综合征
  • 退行性椎间盘疾病
Regions and Countries Covered 欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
Market leaders and key company profiles
  • Boston Scientific Corp
  • Abbott Laboratories
  • Medtronic Plc
  • Biotronik SE & Co KG
  • Nevro Corp
  • Cirtec Medical Corp
  • Synapse Biomedical Inc
    		•
    Get more information on this report

    Europe Spinal Cord Stimulation Device for Chronic Pain Regional Insights

    The regional scope of Europe Spinal Cord Stimulation Device for Chronic Pain refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/europe-spinal-cord-stimulation-device-for-chronic-pain-market-geography.webp
    Get more information on this report
    Identical Market Reports with other Region/Countries

    The List of Companies - Europe Spinal Cord Stimulation Device for Chronic Pain Market

    1. Boston Scientific Corp
    2. Abbott Laboratories
    3. Medtronic Plc
    4. Biotronik SE & Co KG
    5. Nevro Corp
    6. Cirtec Medical Corp
    7. Synapse Biomedical Inc

    Frequently Asked Questions
    How big is the Europe Spinal Cord Stimulation Device for Chronic Pain Market?

    The Europe Spinal Cord Stimulation Device for Chronic Pain Market is valued at US$ 799.87 Million in 2022, it is projected to reach US$ 1,412.01 Million by 2030.

    What is the CAGR for Europe Spinal Cord Stimulation Device for Chronic Pain Market by (2022 - 2030)?

    As per our report Europe Spinal Cord Stimulation Device for Chronic Pain Market, the market size is valued at US$ 799.87 Million in 2022, projecting it to reach US$ 1,412.01 Million by 2030. This translates to a CAGR of approximately 7.4% during the forecast period.

    What segments are covered in this report?

    The Europe Spinal Cord Stimulation Device for Chronic Pain Market report typically cover these key segments-

  • 产品类型 (可充电和不可充电)
  • 应用 (腰椎间盘突出症, 复杂性局部疼痛综合征, 退行性椎间盘疾病)

    • What is the historic period, base year, and forecast period taken for Europe Spinal Cord Stimulation Device for Chronic Pain Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Spinal Cord Stimulation Device for Chronic Pain Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
    • Who are the major players in Europe Spinal Cord Stimulation Device for Chronic Pain Market?

    The Europe Spinal Cord Stimulation Device for Chronic Pain Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Boston Scientific Corp
  • Abbott Laboratories
  • Medtronic Plc
  • Biotronik SE & Co KG
  • Nevro Corp
  • Cirtec Medical Corp
  • Synapse Biomedical Inc
    • Who should buy this report?

    The Europe Spinal Cord Stimulation Device for Chronic Pain Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Spinal Cord Stimulation Device for Chronic Pain Market value chain can benefit from the information contained in a comprehensive market report.

    europe-spinal-cord-stimulation-device-for-chronic-pain-market